California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine (CIRM) is a state agency that supports research and education in the fields of stem cell and gene therapies. It was created in 2004 after 59% of California voters approved California Proposition 71: the Research and Cures Initiative, which allocated $3 billion to fund stem cell research in California. In 2020 voters approved Proposition 14 that allocated additional funds to CIRM. CIRM supports research and training at many stem cell institutes throughout California, including Sanford Consortium, University of California, Santa Cruz, Stanford University, University of California Davis, University of California Irvine, University of California San Francisco, University of California Los Angeles and University of Southern California. In addition, it has supported the establishment of nine "Alpha Stem Cell Clinics" that lead clinical trials for stem cell therapies at City of Hope, University of California San Diego, University of California San Francisco, University of California Davis, a joint clinic at University of California Los Angeles and University of California Irvine, Cedars Sinai, Stanford, and USC/Children's Hospital Los Angeles.